MedMira Three-Minute Rapid HIV Test Revealed Upon FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Canadian firm MedMira will market its Reveal rapid HIV-1 test to U.S. hospitals and clinics through distributor Cardinal Health
You may also be interested in...
Inverness’ Wampole Labs Adds Rapid HIV Test To Point-Of-Care Offerings
Wampole will compete with Orasure in the physician office and point-of-care (PoC) rapid HIV testing market under an exclusive U.S. distribution pact with Efoora for its Rapid HIV test
Inverness’ Wampole Labs Adds Rapid HIV Test To Point-Of-Care Offerings
Wampole will compete with Orasure in the physician office and point-of-care (PoC) rapid HIV testing market under an exclusive U.S. distribution pact with Efoora for its Rapid HIV test
Rapid HIV Testing To Play Key Role In New CDC Prevention Initiative
Efoora Inc. plans to submit the final module of a modular PMA for its rapid HIV test by the end of the month, following the completion of its clinical trial April 4